Inflammation  >>  Solithera (solithromycin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Solithera (solithromycin) / Melinta Therap, Fujifilm Holdings
NCT02628769 / 2014-003077-42: A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary Disease

Terminated
2
6
Europe
Solithromycin, CEM-101, Placebo
Imperial College London, Melinta Therapeutics, Inc.
Pulmonary Disease, Chronic Obstructive
01/17
01/17

Download Options